comparemela.com

Latest Breaking News On - Vivos therapeutics daily - Page 3 : comparemela.com

Vivos Therapeutics (VVOS) Scheduled to Post Earnings on Monday

Vivos Therapeutics (VVOS) Scheduled to Post Earnings on Monday
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Vivos Therapeutics, Inc (NASDAQ:VVOS) Short Interest Update

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 70,600 shares, a drop of 69.7% from the June 15th total of 232,900 shares. Based on an average daily volume of 156,500 shares, […]

Vivos Therapeutics (NASDAQ:VVOS) versus Westaim (OTCMKTS:WEDXF) Critical Survey

Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Westaim (OTCMKTS:WEDXF – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Valuation and Earnings This table compares Vivos Therapeutics and Westaim’s […]

Vivos Therapeutics (NASDAQ:VVOS) & Orthofix Medical (NASDAQ:OFIX) Head-To-Head Review

Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Orthofix Medical (NASDAQ:OFIX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk Vivos Therapeutics has a beta of […]

Orthofix Medical (NASDAQ:OFIX) versus Vivos Therapeutics (NASDAQ:VVOS) Financial Contrast

Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Orthofix Medical (NASDAQ:OFIX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation. Analyst Recommendations This is a breakdown of recent ratings […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.